Skip to content

Clinical trials

Phase 4 Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Clear all

702 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200013
20019
200214
200334
200449
200542
200646
200736
200848
200946
201047
201139
201232
201321
201422
201523
201618
201722
201819
201916
202012
202116
202216
202315
202413
20259
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed469
Unknown status116
Terminated46
Withdrawn27
Recruiting24
Not yet recruiting12
Enrolling by invitation4
Suspended2
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis52
Boehringer Ingelheim26
Sanofi20
Novartis Pharmaceuticals15
Daiichi Sankyo11
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.11
Shanghai Jiao Tong University School of Medicine9
Forest Laboratories8
University of Florida8
Bayer6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension702
Diabetes Mellitus57
Diabetes Mellitus, Type 255
Cardiovascular Diseases33
Renal Insufficiency, Chronic24
Obesity23
Dyslipidemias22
Essential Hypertension20
Metabolic Syndrome20
Coronary Artery Disease18

Trials

Showing 76 to 100 of 702. Each trial links to its page on Pharma Observatory.

602 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.